CLIC1 plasma concentration is associated with lymph node metastases in oral squamous cell carcinoma
Advances in Clinical and Experimental Medicine · 2022
DOI: 10.17219/acem/154621 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Clinical and Experimental Medicine, 2022. Verfasst von Bartosz Paweł Wojtera und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Head and Neck Surgery, Greater Poland Cancer Centre, Poznan University of Medical Sciences, Poland. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Mouth Neoplasms, Head and Neck Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Head and Neck Surgery, Greater Poland Cancer Centre, Poznan University of Medical Sciences, Poland.
- Radiobiology Lab, Department of Medical Physics, Greater Poland Cancer Centre, Poznań, Poland.
- Department of Electroradiology, Poznan University of Medical Sciences, Poland.
Zitieren
APA
Wojtera, B. P., Sobecka, A., Szewczyk, M., Machczyński, P., Suchorska, W. M., & Golusiński, W. (2022). CLIC1 plasma concentration is associated with lymph node metastases in oral squamous cell carcinoma. Advances in Clinical and Experimental Medicine. https://doi.org/10.17219/acem/154621
Vancouver
Wojtera BP, Sobecka A, Szewczyk M, Machczyński P, Suchorska WM, Golusiński W. CLIC1 plasma concentration is associated with lymph node metastases in oral squamous cell carcinoma. Advances in Clinical and Experimental Medicine. 2022. doi:10.17219/acem/154621
BibTeX
@article{Wojtera2022,
author = {Wojtera, Bartosz Paweł and Sobecka, Agnieszka and Szewczyk, Mateusz and Machczyński, Piotr and Suchorska, Wiktoria Maria and Golusiński, Wojciech},
title = {CLIC1 plasma concentration is associated with lymph node metastases in oral squamous cell carcinoma},
journal = {Advances in Clinical and Experimental Medicine},
year = {2022},
doi = {10.17219/acem/154621}
}
EUVIMED